Skip to content

Clinical trials

Phase 1/2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 1/2 Status: Unknown status Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20132
20161
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Commissie Voor Klinisch Toegepast Onderzoek1
Diane George1
Fusion Pharma LLC1
Hospital de Clinicas de Porto Alegre1
Kartos Therapeutics, Inc.1
University of Erlangen-Nürnberg Medical School1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Anemia, Aplastic2
Leukemia, Myeloid, Acute2
Leukemia, Myeloid, Chronic-Phase2
Myelodysplastic Syndromes2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Acquired Immunodeficiency Syndrome1
Anemia, Diamond-Blackfan1
Anemia, Sickle Cell1
Bone Marrow Failure Disorders1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.